5-amino-1mq supplement or peptide or compound 5A-1-Molecule (5 Amino 1mq) 50mg – Pure NNMT Inhibitor 5-Amino-1MQ | ≥99% Pure |

use within 2448 hours [5]

2021 Oct 26;11(5):517-525." Accessed on April 3, 2024, at The BMJ - "Long term health consequences of obesity." Accessed on April 3, 2024, at American Pharmacists Association (APhA) - "Compounding FAQs." Accessed on April 3, 2024, at Centers for Disease Control and Prevention (CDC) - "How Overweight and Obesity Impacts Your Health." Accessed on June 18, 2024, at CDC - "Consequences of Obesity." Accessed on April 3, 2024, at Drugs.com - "Tirzepatide User Reviews for Diabetes, Type 2." Accessed on April 3, 2024, at National Academies Press (NAP) - "Drug Compounding: An Interactive Learning Experience." Accessed on April 3, 2024, at Accreditation Commission for Health Care (ACHC) - "Pharmacy Compounding Accreditation." Accessed on April 3, 2024, at Accreditation Council for Pharmacy Education (ACPE) - "ACPE - Continuing Pharmacy Education." Accessed on April 3, 2024, at PubMed Central (PMC) - "BMJ Open

5-Amino-1MQ belongs to an entirely different class of research compound

The onus of lawful, safe, and appropriate use rests entirely with the purchaser

5-Amino-1MQ is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use

The usual daily recommended amounts of cyanocobalamin, vitamin B12 either through dietary intake or supplementation should be taken during pregnancy (see Dosage)